Arch Aesthetic Plast Surg.  2021 Apr;27(2):69-75. 10.14730/aaps.2020.02383.

Usefulness of meshed SurgiMend in direct-to-implant breast reconstruction

• Eo PS
• Lee JS
• Lee JW
• Choi KY
• Chung HY
• Cho BC
• Lee J
• Park HY
• Yang JD

• KMID: 2515402
• DOI: http://doi.org/10.14730/aaps.2020.02383

Abstract

Background
The use of acellular dermal matrix in implant-based breast reconstruction immediately after mastectomy has attracted attention in recent years because it yields good outcomes. Herein, we analyzed the usefulness of meshed SurgiMend in direct-to-implant (DTI) breast reconstruction.
Methods
In this retrospective single-center analysis, 44 one-stage breast reconstructions using SurgiMend were performed in 42 patients from May 2016 to December 2017. The implant was inserted into the subpectoral plane and SurgiMend was applied to the inferolateral part that lacked tissues to wrap the silicone implant. In 19 patients (20 breasts), fenestration was performed with SurgiMend, while in the remaining 23 patients (24 breasts), SurgiMend that was meshed at a ratio of 1:1.5 was used. We analyzed the frequency of complications. Patient satisfaction was compared and analyzed using a five-item questionnaire (shape, texture, symmetry, pain, and overall outcome).
Results
The average age of the patients was 43.2 years, and their mean body mass index was 21.1 kg/m². The average follow-up period was 24.0 months. In the control (fenestrated SurgiMend) and experimental (meshed SurgiMend) groups, major seroma occurred in five of the 20 breasts (25.0%) and two of the 24 breasts (8.3%), respectively. Minor complications were resolved with conservative treatment. The patient satisfaction score for shape, texture, symmetry, pain, and overall satisfaction was 4.3, 4.1, 4.7, 4.5, and 4.4, respectively.
Conclusions
Applying meshed SurgiMend in DTI breast reconstruction is a useful surgical technique.

Keyword

Breast implants / Acellular dermis / Surgical mesh / SurgiMend